Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Infinity Pharmaceuticals, Inc. (INFI)

« Back to company index

INFI Chatter Timeline

Stock Ticker for INFI

Most Active Tweeters for INFI

UserTweets
@bulletin_en 4
@SleekMoneycom 1
@EnterpriseLeade 1
@stocknewstimes 1
@registrarjourn 1

Recent Tweets for INFI

bulletin_en @bulletin_en
Otonomy Inc. $INFI Comparing side by side https://t.co/SW6VFXqNMB
May 21st 2019, 9:05pm
FlyOnTheWallHQ @FlyOnTheWallHQ
RT @StockWatchHQ: Bristol-Myers Squibb $BMY BOD Expedites Buyout Talks With Infinity Pharmaceuticals $INFI As IPI-549 Monotherapy Data.. ht…
May 19th 2019, 7:05pm
bulletin_en @bulletin_en
Reviewing ImmuCell Corporation $INFI's results https://t.co/5vo4rRajlN
May 18th 2019, 9:05pm
StockWatchHQ @StockWatchHQ
Bristol-Myers Squibb $BMY BOD Expedites Buyout Talks With Infinity Pharmaceuticals $INFI As IPI-549 Monotherapy Dat… https://t.co/jUhAenif7p
May 18th 2019, 7:05pm
1stOncology @1stOncology
#InfinityPharmaceuticals To Present At B. Riley FBR Institutional #InvestorConference $INFI https://t.co/Cl09InJyxs
May 17th 2019, 3:05am
Allstocknews @Allstocknews
$INFI Infinity Pharmaceuticals To Present At B. Riley FBR Institutional Investor Conference From our Stock News Alerts App
May 17th 2019, 12:05am
SleekMoneycom @SleekMoneycom
Infinity Pharmaceuticals Inc. $INFI Receives $3.50 Average Price Target from Brokerages https://t.co/YNWafgocAh #investing
May 17th 2019, 12:05am
stocknewstimes @stocknewstimes
Infinity Pharmaceuticals Inc. $INFI Receives $3.50 Average Price Target from Brokerages https://t.co/UFHJJhrSMR
May 17th 2019, 12:05am
ConsumerFeed @ConsumerFeed
Zacks: Analysts Anticipate Infinity Pharmaceuticals Inc. $INFI Will Post Quarterly Sales of $2.62 Million https://t.co/qUk8leHdWk
May 16th 2019, 10:05pm
ez_alertz @ez_alertz
$INFI Infinity Pharmaceuticals To Present At B. Riley FBR Institutional Investor Conference https://t.co/k0gKQlrxBb
May 16th 2019, 8:05am
DataTrials @DataTrials
$INFI Phase 1 A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics… https://t.co/k0ClfAR8Ks
May 15th 2019, 10:05am
bulletin_en @bulletin_en
Contrasting of Merrimack Pharmaceuticals Inc. $INFI https://t.co/h67zoqLwdh
May 14th 2019, 11:05pm
dakotafinancial @dakotafinancial
Infinity Pharmaceuticals Inc. $INFI Receives $3.50 Consensus Target Price from Analysts https://t.co/ufkt7mZHRL
May 14th 2019, 2:05pm
EnterpriseLeade @EnterpriseLeade
Infinity Pharmaceuticals Inc. $INFI Expected to Post Quarterly Sales of $2.62 Million https://t.co/1AL3Ho3enD
May 14th 2019, 12:05pm
registrarjourn @registrarjourn
Infinity Pharmaceuticals Inc. $INFI Expected to Post Quarterly Sales of $2.62 Million https://t.co/GLe0r0c4Ll
May 14th 2019, 12:05pm
TheMarketsDaily @TheMarketsDaily
Brokerages Set Infinity Pharmaceuticals Inc. $INFI Price Target at $3.50 https://t.co/AvY8LgKFUi
May 12th 2019, 9:05am
AmericanBanking @AmericanBanking
Zacks: Brokerages Anticipate Infinity Pharmaceuticals Inc. $INFI Will Announce Quarterly Sales of $2.62 Million… https://t.co/PpTY6GPQ7Z
May 11th 2019, 2:05am
intercooleronli @intercooleronli
Infinity Pharmaceuticals Inc. $INFI Expected to Post Quarterly Sales of $2.62 Million https://t.co/0L5wYhFJFy #investingnews
May 11th 2019, 2:05am
ledgerzette @ledgerzette
Infinity Pharmaceuticals Inc. $INFI Expected to Post Quarterly Sales of $2.62 Million https://t.co/6cDDmtsFZH #stocks
May 11th 2019, 2:05am
bulletin_en @bulletin_en
Comparison of Adaptimmune Therapeutics plc $INFI https://t.co/g8rUEjs4eD
May 10th 2019, 2:05pm
OlympiaReport @OlympiaReport
Infinity Pharmaceuticals Inc. $INFI Expected to Post Earnings of -$0.15 Per Share https://t.co/Wt1EK0PpFP
May 9th 2019, 2:05pm
AmericanBanking @AmericanBanking
Analysts Expect Infinity Pharmaceuticals Inc. $INFI Will Post Earnings of -$0.15 Per Share https://t.co/I2A0ubxY4z #stocks
May 9th 2019, 2:05pm
dailypoliticaln @dailypoliticaln
Infinity Pharmaceuticals $INFI Announces Earnings Results https://t.co/g6oCzI4xiq
May 9th 2019, 11:05am
AmericanBanking @AmericanBanking
Infinity Pharmaceuticals Inc. $INFI Receives Average Rating of “Hold” from Brokerages https://t.co/b1XP9emk7A #stocks
May 9th 2019, 6:05am
AmericanBanking @AmericanBanking
Infinity Pharmaceuticals $INFI Releases Quarterly Earnings Results, Misses Estimates By $0.19 EPS https://t.co/lUXJS7O6fu #stocks
May 8th 2019, 11:05pm
stocknewstimes @stocknewstimes
Infinity Pharmaceuticals $INFI Issues Earnings Results, Misses Expectations By $0.19 EPS https://t.co/WBxiVw0oCl
May 8th 2019, 11:05pm
SleekMoneycom @SleekMoneycom
Infinity Pharmaceuticals $INFI Issues Earnings Results, Misses Expectations By $0.19 EPS https://t.co/0YeKz3J9uw #investing
May 8th 2019, 11:05pm
FinZTribune @FinZTribune
Contrasting of United Therapeutics Corporation $INFI https://t.co/HhVANWPR5l
May 8th 2019, 8:05am
SiteFocusHQ @SiteFocusHQ
$INFI Qualitative Analysis of recent earnings identified Infinity Pharmaceuticals, Inc (NASDAQ: INFI ) business foc… https://t.co/F7T1zEH1CK
May 7th 2019, 10:05pm
newswelldone @newswelldone
$INFI: Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 …: https://t.co/w03qc2Momh
May 7th 2019, 9:05pm
SeekingAlpha @SeekingAlpha
$INFI - Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2019 Results - Earnings Call Transcript https://t.co/tdNLJQQjLf
May 7th 2019, 9:05pm
Estimize @Estimize
$INFI misses the Estimize EPS Consensus by 19c and the Estimize Revenue Consensus by $6.31M. Reports FQ1 earnings o… https://t.co/Vzpgfdm0Cl
May 7th 2019, 5:05pm
Estimize @Estimize
$INFI reports FQ1 earnings of -24c EPS and $2.14M Revs - https://t.co/iGz3TxmEUH
May 7th 2019, 5:05pm
MarketCurrents @MarketCurrents
$INFI - Infinity Pharmaceuticals misses by $0.08 https://t.co/GTv28KCuDC
May 7th 2019, 4:05pm
Allstocknews @Allstocknews
$INFI Infinity Pharmaceuticals Provides Company Update and First Quarter 2019 Financial Results From our Stock News Alerts App
May 7th 2019, 4:05pm
Stock_News_Now @Stock_News_Now
$INFI: New SEC Filing for INFI: Form 10-Q (No. 0001113148-19-000005): https://t.co/z0v1CFknax
May 7th 2019, 3:05pm
Allstocknews @Allstocknews
$INFI New Form 10-Q for Infinity Pharmaceuticals From our Stock News Alerts App
May 7th 2019, 3:05pm
Estimize @Estimize
$INFI reports after the close, Estimize Consensus -0 EPS and -1.62M Revs compared to WS - https://t.co/sGVpA5Br7C
May 7th 2019, 11:05am
RRaptor01 @RRaptor01
$INFI what to expect for tomorrow’s ER?? Which way will the rocket go?? ???
May 6th 2019, 5:05pm
EnterpriseLeade @EnterpriseLeade
ValuEngine Lowers Infinity Pharmaceuticals $INFI to Sell https://t.co/IK03u5kEWR
May 5th 2019, 11:05pm
registrarjourn @registrarjourn
ValuEngine Lowers Infinity Pharmaceuticals $INFI to Sell https://t.co/88ZNoZrClA
May 5th 2019, 11:05pm
TranscriptDaily @TranscriptDaily
ValuEngine Lowers Infinity Pharmaceuticals $INFI to Sell https://t.co/iQnUKcMbnA
May 5th 2019, 11:05pm
ZolmaxNews @ZolmaxNews
ValuEngine Downgrades Infinity Pharmaceuticals $INFI to Sell https://t.co/OI3dEXGz9f
May 2nd 2019, 6:05pm
macondailynews @macondailynews
Infinity Pharmaceuticals $INFI to Release Earnings on Tuesday https://t.co/BT1eI8z2mQ
May 1st 2019, 11:05am
AmericanBanking @AmericanBanking
Infinity Pharmaceuticals $INFI to Release Earnings on Tuesday https://t.co/ueF9A3hfzE #stocks
May 1st 2019, 11:05am
Allstocknews @Allstocknews
$INFI Infinity Announces the Date of Its First Quarter 2019 Financial Results Conference Call and Webcast From our Stock News Alerts App
April 30th 2019, 8:04am
Stock_News_Now @Stock_News_Now
$INFI: New SEC Filing for INFI: Form EFFECT (No. 9999999995-19-000894): https://t.co/Av8xJzUfAk
April 30th 2019, 6:04am
Allstocknews @Allstocknews
$INFI New Form EFFECT for Infinity Pharmaceuticals From our Stock News Alerts App
April 30th 2019, 6:04am
confcalltran @confcalltran
Infinity Pharmaceuticals Just Received a Notice of Effectiveness https://t.co/3ZysHIRL7g $INFI
April 30th 2019, 6:04am
StockTexts @StockTexts
$INFI Infinity Pharmaceuticals, Inc. SEC Filing: Form EFFECT https://t.co/0qkbwNqBPh
April 30th 2019, 6:04am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.